Pfizer Profits Fall 48 Percent
564654
Drugmaker Pfizer Inc. said Wednesday its second-quarter profit fell 48 percent year-over-year, hurt by the loss of patent exclusivity for its Zoloft and Norvasc drugs and by sluggish sales of blockbuster cholesterol drug, Lipitor, in the U.S.
342707
Bristol-Myers Squibb Co. BMY.N on  Friday reported a lower third-quarter profit as revenue fell  amid intense competition for its products from rivals and  generic drugs.
336164
Bristol-Myers Squibb said its third-quarter profit dipped 16 percent from a year ago to 758 million dollars as the pharmaceutical giant boosted research in the face of expiring patents.
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
194747
Shares in Pfizer Inc  fell around 14 percent in European and pre-opening U.S. trade on Monday after the world's biggest drugmaker scrapped development of its most important experimental medicine.
505706
Global drugs giant Pfizer sees profits fall after a drop in worldwide sales of cholesterol drug Lipitor.
64070
The drug maker said its fourth-quarter profit fell 70 percent from a year-ago period that included the sale of its consumer health business, but adjusted profit topped Wall Street expectations.
82229
Shares in GlaxoSmithKline fall after it issues a profit warning on the back of falling demand for a key drug.
398501
Shares in Pfizer Inc  fell 12 percent in Europe on Monday after the world's biggest drugmaker scrapped development of its most important experimental medicine.
509694
Pfizer Inc.  on Wednesday  reported lower-than-expected quarterly earnings on competition  with generics, and said global sales of cholesterol fighter  Lipitor fell 13 percent amid slipping demand for the company&#39;s  flagship product.
184469
GENEVA  Â The Swiss pharmaceutical maker Novartis said on Thursday that its profit dropped 45 percent in the fourth quarter, citing revamping costs and a weak performance in the United States.
334672
NEW YORK : Bristol-Myers Squibb said its third-quarter profit dipped 16 percent from a year ago to 758 million dollars as the pharmaceutical giant boosted research in the face of expiring patents.
153503
Swiss drugmaker Novartis AG   missed forecasts with a 42 percent drop in  fourth-quarter net profit, hit by generic competition and a  one-off restructuring charge, sending its shares lower.
297628
Merck & Co. MRK.N on Thursday  reported a 28 percent drop in quarterly profit and said 2004  earnings will fall as much as 11 percent due to last month's  recall of its Vioxx arthritis drug.
414238
Stocks inched lower on Friday,  pressured by a sharp drop in Pfizer Inc. PFE.N after the drug  maker said patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
550787
Unilever, the consumer products giant, said today that profits had slipped during the third quarter - as had sales of its top 400 brands.
211417
GlaxoSmithKline PLC reported a 5.8 percent drop in third-quarter net profit Wednesday on strong generic competition and falling sales of its blockbuster diabetes drug in the United States.